Using an online tool for advance care planning in cancer patients
Implementation of Online Advance Care Planning Tool for (Hemato-)Oncological Patients Within the Cancer Network Concord
This study is testing an online tool to help cancer patients plan their future care and make sure their wishes are respected during treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Erasmus Medical Center Academic / other |
| Locations | 1 site (Rotterdam) |
| Trial ID | NCT06350968 on ClinicalTrials.gov |
What this trial studies
This observational study aims to implement and evaluate an online advance care planning tool specifically designed for (hemato-)oncological patients within the Cancer Network Concord. It employs a mixed-methods approach, gathering both quantitative data from patients who have received care in the network and qualitative insights from healthcare providers and patients through interviews. The focus is on understanding how to effectively integrate advance care planning into daily oncological care, ensuring that patient preferences are discussed and respected. The study seeks to enhance the quality of care during the palliative phase of illness for these patients.
Who should consider this trial
Good fit: Ideal candidates for this study are (hemato-)oncological patients aged 18 years and older who have been treated within the Cancer Network Concord.
Not a fit: Patients who are not receiving treatment for cancer or those not affiliated with the CONCORD network may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the quality of end-of-life care for cancer patients by ensuring their preferences are honored.
How similar studies have performed: Other studies have shown promise in implementing advance care planning tools in oncology, suggesting that this approach could be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Cancer * Treated by hospital from the CONCORD-network Exclusion Criteria: \-
Where this trial is running
Rotterdam
- Joica Benschop — Rotterdam, Netherlands (Recruiting)
Study contacts
- Study coordinator: Joica A.M. Benschop, MSc
- Email: j.benschop@erasmusmc.nl
- Phone: +31622586583
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.